We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02116777
Recruitment Status : Suspended (Scheduled Interim Monitoring)
First Posted : April 17, 2014
Last Update Posted : February 13, 2018
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : October 31, 2018
  Study Completion Date : No date given